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Summary 
 
For the past year I have been doing research under the supervision of Dr. Venkatram R. 
Mereddy.  The main focus of this research has been the synthesis and biological evaluation of 
anti-cancer molecules.  This includes extensive organic synthesis, In vitro biology with 
numerous cancer cell lines, and finally In vivo biology with mice.  The In vitro work includes 
mainly cytotoxicity assays against three main cancer cell lines; MDA-231 (triple negative breast 
cancer), MCF-7 (estrogen receptor positive breast cancer), and LnCAP (androgen receptor 
positive prostate cancer).  After initial lead molecules are identified for their toxicity against each 
respective cell line, IC-50 values of these compounds are to be determined to get a 
comprehensive assessment of the toxicity of each respective series of molecules.   
 
Respective lead molecules from each study can then qualify for In vivo studies.  Currently, 
privileged molecules are being screened for general In vivo toxicity in mice.  This initial 
screening is done by injecting our compounds (10% DMSO solution) into the lower abdomen.  
This study is done for 21 days and toxicity is noted by observing the weight of the animals every 
three days over the course of the study.  Following toxicity evaluation, the molecules will be 
screened for their In vivo tumor reduction capabilities.  Nude mice will be injected with cancer 
and tumors will be developed.  Our molecules will then be injected In situ, and tumor reduction 
will be noted.   
 
The mentioned studies are those currently being established.  Plenty more In vivo studies are still 
to be done in order to result in a molecule making it to the clinic for the overall purpose of cancer 
patient health benefits.   
 
Organic Synthesis 
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The reaction scheme above has been applied to 20+ derivatives of a molecule.  Step one involves 
condensation of a carboxylic acid and an amine, and step two involves the coupling of and 
aldehyde with the newly formed amide.  Purification was done largely through acidification and 
filtration, however, each derivative had to be treated slightly different in each case according to 
the functional groups present.  Purity of each compound was confirmed by proton NMR 
spectroscopy. 
 
Discussion 
 
Overall, the objectives presented in this project have been achieved.  The process of organic 
synthesis went very well in that 20+ derivatives have been prepared and purified, according to 
proton NMR spectroscopy.  Also, in vitro biological studies of each molecule on three cancer 
cell lines (noted in the summary) have been completed.  This gives us a good indication of which 
molecules can and should be tested further with animals.  Also, an In vivo model has been 
established to test the general toxicity of the compounds in mice, which will lead to further 
indication of their effectiveness as a chemotherapeutic agent. 
 
